Several abstracts featuring data from NCDR’s family of registries – including the CathPCI Registry, the SVS VQI Registry (formerly known as the PVI Registry) and STS/ACC TVT Registry – were presented at SCAI 2024, held May 2-4 in Long Beach, CA.

Abstracts presented at the meeting include:

Impact of Long-Term LVEF Trajectories on Outcomes After Primary PCI For Anterior STEMI
Revathy Sampath-Kumar, MD, from UC San Diego Health used data from the CathPCI Registry in 210 patients (mean age 60 ± 13, 79% men) to evaluate the impact of long-term left ventricular ejection fraction (LVEF) trajectories on patient outcomes and found that patients with decreased LVEF or consistently reduced LVEF after primary PCI for anterior STEMI exhibited higher rates of all-cause mortality at 10-year follow up. View the abstract.

Relationship Between Periprocedural Blood Draws and In-Hospital Bleeding Events After PCI
Meghana Iyer, BS, from Cleveland Clinic Lerner College of Medicine presented data from the CathPCI Registry investigating the relationship between blood draws post PCI and periprocedural bleeding risk. Results showed a strong association between the number of blood draws within 72 hours post-procedure and increased risk of NCDR defined bleeding events, which may contribute to asymptomatic bleeding events. View the abstract.

Patient Characteristics and Outcomes of Radial to Femoral Access-Site Crossover
Factors associated with the need for radial to femoral access-site crossover during radial PCI were age >70 years and vasopressor support at time of PCI, indicating these patients may benefit from an initial femoral approach. Authored by Revathy Sampath-Kumar, MD, from UC San Diego Health, the abstract included 3,037 patients (mean age 67 ± 12, 45% had acute coronary syndrome) captured by the CathPCI Registry and assessed patient and procedure level predictors of radial to femoral crossover, complications, and all-cause mortality within one year after PCI. View the abstract.

Predictors of Adverse Events Following Endovascular Revascularization of Acute Limb Ischemia: Outcomes of the NCDR PVI Registry
Matthew S. Herzig, MD, from Beth Israel Deaconess Medical Center used data from the PVI Registry to estimate contemporary rates of acute limb ischemia and identify predictors of adverse in-hospital outcomes. Among 3,541 endovascular procedures from 2014 to 2020, Herzig found that despite the declining incidence of acute limb ischemia, adverse event rates remain high with significant predictors of death or amputation including severe lung disease, Rutherford Class IIb and end stage renal disease. View the abstract.

AKI After TAVR: A Bad Omen?
Shahan Haseeb, MD, from Northwell Health Mather Hospital assessed the impact of acute kidney injury (AKI) on the in-hospital outcomes of TAVR patients, including 1,796 patients from four New York metropolitan area hospitals captured by the STS/ACC TVT Registry between 2021 to 2022. AKI after TAVR was associated with a significant increase in bleeding complications, pacemaker implantation and in-hospital mortality rates. View the abstract.

TAVR After CABG Surgery: Looking Good But We Should Keep Looking
When looking at in-hospital outcomes of TAVR patients with and without a history of prior CABG, Shahan Haseeb, MD, from Northwell Health Mather Hospital found that although mortality rates were three-times higher in TAVR patients with a past CABG procedure, results were not statistically significant, indicating a need for additional analysis with a larger patient cohort. Haseeb included 1,796 patients from four New York hospitals from the STS/ACC TVT Registry between 2021 to 2022, finding similar rates of in-hospital bleeding complications, vascular complications, post-TAVR pacemaker implantations and stroke between the two groups. View the abstract.

Additional highlights featuring NCDR data:

In-Hospital Results With Intravascular Lithotripsy in the Real-World: Outcomes From the ACC NCDR CathPCI Registry
Dean J. Kereiakes, MD, FACC
Thursday, May 2, 3:40-3:45 p.m. PT
Exhibit Hall A: Andreas Grüntzig Abstract Theater 2

Temporal Trends and Clinical Outcomes With Radial vs. Femoral Arterial Access For PCI in the U.S.
Reza Fazel, MD, FACC
Thursday, May 2, 9:17-9:24 a.m. PT
104A